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Abstract
Acute and chronic forms of inflammation are known to affect liver responses and susceptibility to disease and injury.
Furthermore, intestinal microbiota has been shown critical in mediating inflammatory host responses in various animal
models. Using C. rodentium, a known enteric bacterial pathogen, we examined liver responses to gastrointestinal infection
at various stages of disease pathogenesis. For the first time, to our knowledge, we show distinct liver pathology associated
with enteric infection with C. rodentium in C57BL/6 mice, characterized by increased inflammation and hepatitis index scores
as well as prominent periportal hepatocellular coagulative necrosis indicative of thrombotic ischemic injury in a subset of
animals during the early course of C. rodentium pathogenesis. Histologic changes in the liver correlated with serum
elevation of liver transaminases, systemic and liver resident cytokines, as well as signal transduction changes prior to peak
bacterial colonization and colonic disease. C. rodentium infection in C57BL/6 mice provides a potentially useful model to
study acute liver injury and inflammatory stress under conditions of gastrointestinal infection analogous to
enteropathogenic E. coli infection in humans.
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Introduction
Liver responses under acute and chronic forms of inflammation
have gained considerable interest, particularly due to the role of
inflammation in alcoholic liver disease (ALD), non-alcoholic
steatohepatitis (NASH) [1,2], ischemia/reperfusion (I/R) injury
[3,4], and drug-induced liver injury (DILI) [5,6]. The complexity
of these responses is underscored by the liver’s key role in innate
immunity, providing initial defense against microbes, bacterial
products, and toxins traversing the intestinal barrier [7,8].
Furthermore, understanding the host response to environmental
pathogens and chemicals is critical in order to study how exposure
may amplify, synthesize with, or mitigate hepatic injury and
disease. While genetic manipulation and pharmacological inhibi-
tion have facilitated our understanding of hepatic homeostasis
under inflammatory stress conditions, there are few animal models
that can reliably predict these pathological perturbations in
humans.
Citrobacter rodentium (C. rodentium) is an enteric bacterial pathogen
that causes varying degrees of intestinal inflammation, hyperplasia,
and edema in numerous strains of mice [9,10,11]. As a murine
homolog of enteropathogenic Escherichia coli (E. coli) (EPEC), C.
rodentium infection in mice is widely used as an animal model to
study these human infections; it provides a reproducible, robust,
and physiologically relevant model of inflammation. More
recently, C. rodentium infection has demonstrated organ-specific
effects distal to the primary site of attachment and disease. These
include alterations of phase I (cytochrome P450s) and phase II
(glucuronosyltransferases (UGTs)) metabolic enzymes in liver and
kidney, as well as increases in hepatic cytokine transcript [12,13]; a
time course of regulation that follows colonic inflammation and
bacterial colonization, peaking at 7–10 days post inoculation
(DPI), and returning to normal by 15–24 DPI. Changes in local
and systemic cytokines have been implicated in metabolic
dysregulation potentially altering host susceptibility to injury and
disease [14]. Furthermore, altered phase I/II enzymes, which are
associated with biosynthesis and catabolism of endogenous
substrates, as well as clearance of numerous pharmaceuticals,
could be of clinical significance for patients presenting with liver
diseases, inflammatory bowel syndromes, or pathogenic gastroin-
testinal infections.
Here we examined the host response to C. rodentium at various
stages in the course of enteric infection, focusing particularly on
systemic and liver-specific cytokine protein profiles. For the first
time, we show distinct liver pathology associated with enteric
infection with C. rodentium in C57BL/6 mice, characterized by
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33099portal vein thrombi and associated periportal ischemic necrosis
during the early stages of pathogenic infection (3 DPI) in a subset
of animals. Hepatic injury and inflammation correlated with
serum elevation of liver transaminases, systemic and liver resident
cytokines, as well as signal transduction changes prior to peak C.
rodentium colonization and colonic disease.
Results
Infection kinetics and C. rodentium-induced histological
colonic changes
Although dependent on mouse strain, C. rodentium colonization
levels in the colon typically peaks 5–14 DPI with approximately
10
9 colony-forming units (CFU)/g feces [9]. As previously
reported, fecal shedding of C. rodentium in C57BL/6 mice reached
a maximum of ,10
9 CFU/g feces [15], with detectable levels 3
DPI, peaking 7 DPI, and clearance beginning as early as 10 DPI
(Figure S1A). Body weight changes were not significant over the
course of infection (Figure S1B); consistent with previous findings
that C. rodentium infection in adult C57BL/6 mice results in self-
limiting disease with minimal morbidity and mortality [9,10,16].
Histomorphological changes and disease severity scores of
hematoxylin and eosin (H&E) stained sections of the ileo-cecal
junction and colon were tabulated by a board certified veterinary
pathologist (SM) blinded to study treatment groups (Figure 1).
Intact epithelium with none to minimal changes were noted in the
control animals; however in the infected group as early as 3 DPI,
epithelial defects, colonic foci of inflammation, edema, and
hyperplasia were observed (Figure 1A and 1B) with statistically
significant increases in inflammation, edema, and epithelial defects
by 7 DPI (P,0.05, Kruskal-Wallis with Dunn’s post test), and
reaching maximal severity by 14 DPI (Figure 1C and 1D).
Significant changes in crypt atrophy and epithelial hyperplasia
were only observed at 14 DPI (Figure 1D)( P ,0.05 and P,0.01
respectively). In adult C57BL/6 mice, disease peaks approximately
2 weeks post inoculation (WPI) with recovery and full clearance of
C. rodentium by 4 WPI and resolution of colonic lesions by 6 WPI
[9,10,17].
C. rodentium-induced liver inflammation and necrosis
While the effect of C. rodentium infection has been well
characterized with respect to colonic changes, we decided to
examine in greater detail the effect of C. rodentium infection on liver
homeostasis. C. rodentium induced histological changes as early as 3
DPI in liver sections that reached statistical significance at 7 DPI
(portal inflammation, lobular inflammation, interface inflamma-
tion, number of lobes with .5 inflammatory foci, and hepatitis
index), with moderate improvement noted by 14 DPI (Figure 2E).
The overall hepatitis index of 4 or more is a more convincing
feature of true hepatitis and this was observed more often at later
time points. Control livers had none to minimal observable
histological abnormalities, however, in infected animals at 3 DPI,
the appearance of foci of inflammation indicated a pro-
inflammatory state with multifocal coagulative necrosis observed
in 3/6 mice (Figure 2A–D). Necrotic lesions presented primarily
with a periportal pattern of distribution (Figure 2G) and were
indicative of thrombotic ischemic injury with the presence of
portal venular fibrin thrombi. Necrotic regions contained
hepatocytes with eosinophillic cytoplasms, appearance of pyknotic
or absent nuclei, and loss of normal cellular architecture. To
Figure 1. C. rodentium-induced colonic effects in C57BL/6 mice. (A) Mock inoculated animals at 0 DPI with normal colonic architecture where
epithelial integrity and goblet cells appear intact. (B) Colon at 3 DPI showing epithelial defects at the top of the crypt. (C) Colon at 14 DPI
demonstrating hyperplastic crypts and depletion of goblet cells. (D) C. rodentium induced statistically significant histological changes as early as 7 DPI
(inflammation, edema, epithelial defects) in colonic sections and found to be most dramatic at 14 DPI. Crypt atrophy and minimal dysplastic changes
were only noticeable at 14 DPI. Changes in inflammation, edema, epithelial defects, and hyperplasia as early as 3 DPI were noted, but failed to reach
statistical significance (Kruskal-Wallis non-parametric test with Dunn’s multiple comparison test: * P,0.05, ** P,0.01, *** P,0.001). Symbols indicate
individual animals and lines indicate group means.
doi:10.1371/journal.pone.0033099.g001
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processed for alanine amino transferase (ALT), the levels of which
are known to rapidly increase and persist subsequent to liver
injury. Hepatic necrosis score correlated with increased ALT at 0
vs 3 DPI=(28.6062.358 U L
21 N=5 versus 415.26250.4 U L
21
N=6). The three mice with hepatocellular necrosis had ALT
levels 56, 16, and 13-fold higher than average control values
(ALT=1603, 464, and 359 U L
21 respectively), while mice
without these hepatic lesions at 3 DPI, had ALT levels comparable
to 0 DPI controls (Figure 2F).
Necrotic livers were further characterized by immunohistolog-
ical staining for activated caspase 3 and Ki-67 and revealed
increased labeling index of both markers in periportal areas of
injury indicating heterogeneous regions of cell death and active
proliferation (Figure 3). Livers harboring necrotic lesions at 3 DPI
contained a statistically higher incidence of positively stained cells
for Ki-67, as compared to controls and those without lesions at 3
DPI, indicating a proliferative state in these livers with a
comparable increase in labeling index at 7 and 14 DPI
(Figure 4A and 4B). Animals at 7 and 14 DPI did not harbor
obvious necrotic lesions or elevations in ALT; however, the
presence of large hepatocytes and areas of necro-granulomatous
inflammation indicated that prior acute hepatic necrosis in these
animals may have resolved.
Serum cytokine and chemistry changes due to C.
rodentium infection
C. rodentium has been shown to induce numerous immune
regulators at both systemic and local tissue levels, and are generally
associated with a mucosal Th1/Th17-mediated response in
C57BL/6 mice [18,19]. Recently, serum and colon matched
cytokines were analyzed in C. rodentium infected C57BL/6 mice at
peak colonic disease (14 DPI), demonstrating correlations of colon
and systemic levels associated with disease severity [20]. Here we
Figure 2. C. rodentium-induced necrosis and histological liver changes in C57BL/6 mice. (A) Control livers appeared normal with minimal
observable histology. (B) At 3 DPI the appearance of a focus of lobular injury and inflammation indicating a pro-inflammatory state (indicated by #).
(C) Multifocal venous thrombi and associated periportal hepatocellular coagulative necrosis (indicated by *) was observed at 3 DPI suggestive of
thrombotic ischemic injury. (D) Higher magnification (4006) view showing necrotic hepatocytes with eosinophilic cytoplasm, appearance of pyknotic
or absence of hepatic nuclei, and loss of normal cellular architecture. (E) C. rodentium induced histological changes as early as 3 DPI in liver sections,
statistically significant at 7 DPI (portal, lobular, interface inflammation, # lobes with .5 inflammatory foci, and hepatitis index score), with moderate
improvement by 14 DPI. (F) The degree of necrosis determined by pathological assessment as well as serum ALT measurements. (G) The pattern of
necrosis was assessed as centrilobular, midzonal, or periportal in distribution. (Kruskal-Wallis with Dunn’s post test compared to controls: * P,0.05,
** P,0.01, *** P,0.001). Symbols indicate individual animals and lines indicate group means.
doi:10.1371/journal.pone.0033099.g002
Citrobacter rodentium-Induced Liver Necrosis
PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e33099measured both serum-specific changes in cytokines/chemokines as
well as serum chemistries at early, peak, and resolving timepoints
of bacterial clearance (Figures S2 and S3). Numerous circulating
cytokines and chemokines were significantly induced at 3, 7, and
14 DPI. Findings at 3 DPI were particularly interesting given that
they correlated with histological findings in the liver and preceded
peak colonic bacterial colonization and disease. Circulating
cytokines were significantly elevated for IL-2, G-CSF, GM-CSF,
MCP-1, MIP-1b, and RANTES at 3 DPI as a group (P,0.05, by
one way ANOVA with Tukey’s multiple comparison test).
Elevations in IL-10 and KC were noted but did not reach
statistical significance. For the majority of cytokines/chemokines
measured, mice at 7 DPI appeared to have the highest circulating
levels correlating with peak fecal C. rodentium shedding (Figure
S2). This included elevations in pro-inflammatory (IL1b, IL-6, and
TNF-a), immunomodulatory (IL-2, IL-12p70, IL-17), Th2 (IL-4,
IFN-c), and macrophage chemotaxis/activation (GM-CSF, MIP-
1b)( P ,0.001) when compared to 0 DPI controls.
Serum cholesterol levels also increased significantly at 3 DPI
and continued to rise until 14 DPI. It has been shown that C.
rodentium can alter the transcriptional levels of certain phase I/II
metabolic enzymes in both liver and kidney associated with
metabolism of endogenous and pharmaceutical substrates [12,13].
Cholesterol’s clearance from the circulation is partially mediated
by oxidation via CYP 7A1, and we have shown decreases in
CYP7a1 transcript in livers of mice infected with C. rodentium (data
not shown). Significant increase in blood urea nitrogen (BUN) was
noted at 14 DPI (P,0.01) as well as decreases in creatine
phosphokinase (CPK) at 7 and 14 DPI (P,0.05 and P,0.01
respectively). Total bilirubin at 14 DPI was also decreased
(P,0.01). Other serum chemistries and electrolytes measured,
including albumin and glucose, were normal and did not vary
significantly across monitored timepoints (Figure S2).
Liver cytokine and signaling changes due to C. rodentium
infection
To determine if systemic cytokine and chemokine profiles
correlated with local levels in the liver, we analyzed lysates using
23-plex cytokine/chemokine panels and noted numerous targets
that increased in serum that were also similarly upregulated in
livers at 3 DPI (Figure S4). Liver levels of IL-1b (L), G-CSF (L),
KC (L), MCP-1 (L), MIP-1a (L), and RANTES (L) were elevated
at 3DPI. Given that cytokines are known signaling molecules, we
also measured signal transduction in liver lysates using multiplex
phospho-kits, monitoring both total and phosphorylated forms of
JNK, Akt, ERK1/2, p38, IkBa, and STAT3 (phosphorylated
species only) (Figure 5). STAT3 showed increases in livers with
necrotic lesions as confirmed by western analysis (data not shown),
with lower, but sustained activation at 7 and 14 DPI (Figure 4C).
Akt activation, assessed by the ratio of phosphorylated/total Akt,
was upregulated at 14 DPI (P,0.05), although levels elevated at 3
and 7 DPI did not reach statistical significance (Figure 5).
Phosphorylation of IkBa, which results in proteasome-mediated
degradation and subsequent activation of Nf-kB, was increased in
animals with necrotic lesions at 3 DPI, indicating potential
activation of pro-inflammatory and tissue repair mechanisms
associated with this transcription factor. IkBa activation missed
significance as a group when compared to 0 DPI controls but was
statistically significant when compared to livers at 14 DPI
(P,0.05).
Multivariate analysis uncovers serum and tissue cytokines
and chemokines that discriminate hepatic necrosis
Analysis of data based on averages in representative groups can
result in oversight of important correlations noted on an individual
animal basis. We therefore used a multivariate computational
Figure 3. Activated caspase 3 and Ki-67 in C. rodentium-induced liver lesions. Control livers showed minimal staining for the apoptotic
marker activated caspase 3, and proliferative marker Ki-67 (far left panels), while livers with necrosis at 3 DPI stained positively for both markers with a
periportal pattern of distribution (middle (1006) and far right (2006)). Pictured is a representative liver section that was serially sectioned and
immunostained independently for each cellular marker.
doi:10.1371/journal.pone.0033099.g003
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compendium leveraging its multiplex nature. PLS-DA (Partial
Least Squares Projection to Latent Structures - Discriminant
Analysis) and OPLS (Orthogonormalized Partial Least Squares
Regression) were used to determine variables with the highest
discriminatory power for mice with necrotic lesions at 3DPI.
Furthermore, these analyses were used to determine features that
correlate best with serum ALT, a known biomarker of liver
necrosis. We developed non-invasive models (serum targets only),
tissue level model (liver targets only), and a combined model
including both types of features. The serum PLS-DA model
resulted in adequate separation of lesion bearing vs non-lesion
bearing animals (Figure 6A), with dummy variables (Y) based on
this classification covarying with serum targets that make up the
principal components plane (Figure 6B). Their relative impor-
tance as discriminators was assessed by their variables in
projection (VIPs) score for the principal component 1, where
values .1 have positive influence in discriminating between classes
and VIP ,1 are less influential (Figure 6C). Similarly, using
OPLS regression which reduces dimensions on the basis of their
covariance with a specified dependent variable (Y, serum ALT)
(principal component 1 – predictive), while ignoring targets
orthogonal to this vector (principal component 2 – orthogonal)
also resulted in clear separation of animals based on this classifier
(Figure 7). PLS-DA serum models uncovered ALT, AST,
immune modulators (IL-6, IL-10), monocytes chemokines/activa-
tors (MIP-1a, MCP-1), neutrophil chemokines/activators (G-CSF,
KC), and T-cell activation (RANTES) as enriched in animals with
hepatocellular necrosis (Figure 6 C).
This method was repeated for tissue markers (Liver PLS-DA
Figure 8, and OPLS Figure 9) and resulted in a large overlap
with the serum specific targets; immune modulators (IL-1a (L), IL-
6 (L), IL-12p40 (L)), monocytes chemokines/activators (MIP-1a
(L), MIP-1b (L), MCP-1 (L)), neutrophil chemokines/activators
(G-CSF (L), KC (L)), and T-cell activation (RANTES (L)) as
enriched in mice with hepatic necrosis. Combining both serum
Figure 4. C. rodentium significantly increases Ki-67
+ labeling index and STAT3 phosphorylation in livers. (A) Top panels are 2006and
lower panels are 4006views of the same frame. Brown-colored pigment indicates positively stained cells for Ki-67. (B) Average number of Ki-67
+
cells/mm
2 liver determined in 15 fields (magnification, 4006, 3 fields/lobe) per mouse (n=3 for 0, 7, and 14 DPI; n=2 for 3 DPI (NEC); n=1 for 3 DPI
(No NEC)). Data is represented as box-whisker plots, where boxes represent the first to third quartile and a horizontal line indicates the median. Bars
represent ranges. (One-way ANOVA with Tukey’s multiple comparison test: *** P,0.001). (C) P-STAT3 levels in liver lysates were detected using a Bio-
Rad phosphoprotein panel and expressed as a fold change of mean fluorescence intensity (MFI) relative to controls (0 DPI). STAT3 was significantly
activated in livers of mice inoculated with C. rodentium at 3 and 7 DPI (Kruskal-Wallis test with Dunn’s multiple comparisons test: * P,0.05,
** P,0.01).
doi:10.1371/journal.pone.0033099.g004
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and the relative VIPs compared (Figure 10). The results of PLS-
DA and OPLS models generated using serum targets, liver targets,
and combined targets are summarized in Table 1. Overall, both
serum and tissue models were effective in discriminating both the
presence of necrosis and it’s severity. The tissue models were
slightly better independently than the serum models, and the
combined (serum + tissue) analysis gave the highest R
2Y
(cumulative) and Q
2 (cumulative) with the least number of
components. The non-invasive method of serum cytokine
detection makes this arguably a more attractive method, even
with a modest loss in model prediction.
Discussion
In the present study we characterized the systemic and liver
effects of C. rodentium infection in female C57BL/6 mice at early,
peak, and resolving timepoints of bacterial clearance. We
demonstrated systemic targets (cytokines/chemokines and serum
chemistry markers) that differentiated mice with and without tissue
changes by PLS-DA. Systemic elevations in ALT, AST, with an
upregulation of immune modulators (IL-6, IL-10), monocytes
chemokines/activators (MIP-1a, MCP-1), neutrophil chemokines/
activators (G-CSF, KC), and T-cell activation (RANTES) at
3 DPI correlated with coagulative liver necrosis, with a pre-
dominant periportal distribution in association with venous (portal)
fibrin thrombi. Mice harboring liver lesions also demonstrated
induction of STAT3 and IkBa phosphorylation, coupled with liver
specific protein elevations of IL-1b (L), IL-6 (L) G-CSF (L),
KC (L), IL-12p40 (L), MCP-1 (L), MIP-1a (L), and RANTES
(L). These changes occurred prior to peak C. rodentium coloniza-
tion in the absence of significant co-existing colonic lesions and
disease.
Pathological assessment of livers indicated that 50% of mice at 3
DPI had periportal necrotic lesions associated with portal vein
fibrin thrombi that have not been observed and/or previously
reported in this murine model. These results have been repeated in
our lab in subsequent studies (unpublished results). This may be
due in part to the fact that 3 DPI is early in colonic disease
pathogenesis coupled by our interest in investigating an organ
distal to the primary site of disease pathology and bacterial
colonization. Bacterial translocation due to inflammation or
overgrowth of commensal bacteria has been shown to occur, with
translocation of luminal bacteria to other organs [21,22], in some
cases resulting in sepsis and the subsequent death. Furthermore, C.
rodentium has demonstrated translocation to MLNs during infection
course [23]. We did not culture liver tissues to determine levels of
C. rodentium colonization but follow-up experiments in which liver
sections are stained using a C. rodentium-specific antibody could
confirm hepatic colonization. C. rodentium has been associated with
disruption of tight junctions and barrier function in intestinal
epithelial cells in vitro and in vivo [24,25]. Given liver lesions were
predominantly periportal in their pattern of distribution, and
indicative of thrombotic ischemic injury with the presence of
portal vein thrombi, it is likely that bacterial components, or C.
rodentium (live or dead) at the early stages of bacterial colonization,
Figure 5. Signal transduction changes in liver due to C. rodentium infection. The phosphorylated/total mean fluorescence intensity (MFI)
ratios were determined for liver lysates (5 mg total protein) harvested from animals over the course of C. rodentium infection. Average Akt activation
was significantly increased at 14 DPI with comparable elevations at 3 and 7 DPI missing statistical significance. Elevations were observed in IkBa
phosphorylation, particularly in mice with hepatic necrosis, demonstrating statistical significance as a group versus 14 DPI livers. ERK1/2 and p38
failed to demonstrate significant changes over the course of C. rodentium infection in livers (One-way ANOVA with Tukey’s multiple comparison test:
* P,0.05, ** P,0.01, *** P,0.001). Data presented as mean 6 SEM.
doi:10.1371/journal.pone.0033099.g005
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inducing systemic and hepatic inflammatory processes. Lipopoly-
saccharide (LPS), for example, through interaction with LPS-
binding protein and TLR4 has been demonstrated to induce fibrin
clots in tissues [26]. LPS has also been shown to induce expression
of ATP-binding cassette transporter A1 (ABCA1), a transporter
known to promote apolipoprotein-dependent cholesterol efflux
from cells, with cholesterol participating in the removal of LPS
[27], which could contribute to elevated levels of cholesterol noted
in our study. Alternatively, it is also possible that at early stages in
the pathogenesis of C. rodentium, coagulative factors such as PAI-1
may be altered. These factors have been associated with increased
portal vein thrombosis (PVT) in patients with liver diseases [28]
and increased fibrin deposition in LPS models of idiosyncratic liver
injury [29], warranting future analysis of hemostatic factors in this
model. It has been proposed that the liver may act to trap LPS,
along with other bacterial components as a protective mechanism
to prevent systemic spread of bacteria. As a regenerative organ,
minimal necrosis via coagulative mechanisms may be manageable
in the liver, and preferable to dissemination of these products to
other organs and generating a systemic inflammatory response.
The presence of necro-granulomatous inflammation at later
timepoints indicates residual effects of hepatic mechanisms to
repair prior hepatic injury in these animals. The lack of increased
circulating ALT indicates that active necrosis was likely not
occurring at 7 and 14 DPI, indicating transient injury.
Using PLS-DA and OPLS modeling, we demonstrate an
upregulation of targets associated with necrosis at 3 DPI (for total
list see Figure 10). G-CSF (S/L), MCP-1 (S), KC (S/L), IL-6 (S/
L), IL-10 (S), and RANTES (S/L) were highly predictive for
animals with hepatocellular necrosis and demonstrated high
covariation with ALT. Neutrophil activation is commonly
observed at the site of tissue injury. Indeed, G-CSF, a chemokine
known for neutrophil recruitment and activation, was elevated in
serum and liver homogenates. G-CSF is also known to promote
the survival, proliferation, differentiation, and function of both
precursor and mature neutrophils. The increased levels of G-CSF
may also account for the induction of STAT3 and Akt levels found
in the liver. Interestingly, IL-6 can inhibit the inflammatory
response induced by neutrophil-activating chemokines by facili-
tating neutrophils apoptotic clearance [30,31]. Mechanistically,
this has been demonstrated to be a result of STAT-3 activation in
a model of acute peritoneal infection [32]. Deregulation of gp130
(IL-6 receptor) signaling in this model did not affect the initial
CXCL1/KC-driven neutrophil recruitment, indicating early
induction of these chemokines is IL-6 independent [32]. IL-10
(S) was also elevated in necrotic bearing mice in our model, a
cytokine with known hepatoprotective affects in drug-induced liver
injury. IL-10 can regulate KC levels in vivo attributable to
modulation of STAT 1 and STAT3 (non-gp130 mediated)
signaling [33], as well as iNOS levels in an acetaminophen-
induced model of liver injury [34,35].
Figure 6. Serum-specific PLS-DA analysis of C. rodentium infected C57BL/6 mice at 3 DPI. (A) Partial least squares discriminate analysis
(PLS-DA) showing separation of mice with and without necrosis using the first two principal components. (B) Cytokine covariation based on class
discrimination using cytokine targets as independent variables (X, black triangles) and pathological states (presence of absence of necrotic lesions)
as the dependent dummy variables (Y, red squares). (C) Variables in projection (VIPs) for principal components 1 and 2, where targets with values
.1 have positive influence in discriminating between classes. Table represents the serum-specific VIPs and their respective scores that best
discriminate necrotic from non-necrotic mice at 3 DPI.
doi:10.1371/journal.pone.0033099.g006
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with hepatic necrosis, these cytokines are implicated in the process
of hepatic inflammation and are known to recruit monocytes and
lymphocytes during liver injury. MCP-1 is primarily secreted by
monocytes, macrophages, and dendritic cells. It activates macro-
phages and has chemotactic activity for monocytes [36] and
basophils but not for neutrophils or eosinophils. MCP-1 is also
associated with numerous models of fibrosis, and has been shown
to activate hepatic stellate cells, which play a major role in hepatic
fibrosis. In the current study, the occurrence of portal vein thrombi
in livers with hepatic necrosis, paralleled increases in serum and
liver MCP-1 demonstrated by PLS-DA. Analysis at 3 DPI also
showed covariation with P-IkBa; a known regulator of Nf-kB
transcription. P-IkBa has also shown to function in an autocrine
loop with RANTES, and demonstrated a high correlation with
MCP-1 (R
2=0.84) in our study (Figure S5 comparing 3 and 7
DPI networks). Collectively, the regulatory control by both STAT
and Nf-kB mediated transcription deserve further exploration of
their precise roles in mediating the responses to early infection and
liver inflammation and injury in this model.
Liver responses detected in infected animals at 3 DPI
overlapped many targets associated with acute colitis and disease
severity including MCP-1, MIP-1a, MIP-1b, RANTES, and KC
and neutrophil/Th17-related targets such as KC, IL-1b, IL-6, IL-
Figure 7. Serum-specific OPLS analysis of C. rodentium infected animals at 3 DPI. OPLS analysis of C. rodentium infected animals at 3 DPI
using serum cytokines and chemistries (X) for prediction of ALT levels (Y). (A) Mice segregated well in the predictive component (principal
component 1) with an R
2X (1)=0.35, indicating this component captured ,35% of the variance present in the X variables. (B) The predictive weight
and covariation of serum targets (X variables, black triangles) in relation to serum ALT (Y, red square). (C) The variables that best separate
the two pathological states in relation to the predictive component. (D) Variables in projection (VIPs) for the predictive component where values
.1 are have positive influence in determining ALT levels, and VIP ,1 have less predictive influence. (E) Observed vs predicted plot for ALT resulted
in a R
2=0.9892 indicating a highly predictive model based on serum cytokines. (F) Table representing the VIPs for the predictive component for
serum ALT.
doi:10.1371/journal.pone.0033099.g007
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stimuli are a substantial source of circulating cytokines [37]. Portal
circulation potentially containing bacterial components and/or
cytokines and chemokines drains the intestines before entering the
systemic circulation [38]. It is possible that these cytokine
responses are generalized systemic responses to the presence of
bacterial products, but may also indicate a specific liver response
to distal infection in the gut. Indispensable for metabolic processes,
the liver is also a key ‘‘immunologic’’ organ [8]. Hepatic perfusion
with venous blood return from the gastrointestinal tract highly
enriched with microbial antigens provides early host defense
against microbes and toxins translocating across the gut wall [7].
Recently, severe necrotizing hepatitis was observed in IL-10 KO
mice orally infected with the enteric parasite Trichinella spiralis [39].
Douglas et al demonstrated the critical role of IL-10 to mediate the
trafficking of intestinally derived CD4
+ T-cells expressing the IL-4
cytokine required for neutrophil-dependent necrosis. Sequestra-
tion of activated neutrophils was shown to be dependent on IL-4,
and while neutrophil depletion alleviated necrosis, this was not
required for initiation of injury. Thus, enterohepatic cytokine
balance is important for appropriate hepatic immune function.
Serum IL-10 was induced in C. rodentium-infected animals at 3 DPI
and associated with coagulative necrosis. A regulatory cytokine,
IL-10, exerts influence on numerous immunological activities such
as antigen presentation and cytokine production, and is involved
in the initiation and maintenance of inflammation [40]. Induction
of intestinal inflammation using dextran sulfate sodium (DSS)
during experimental NASH promotes translocation of LPS,
hepatic inflammation, and fibrogenesis [41]. Helicobacter hepaticus
(H. hepaticus), another enteric pathogen known to induce
spontaneous, chronic colitis in certain susceptible mouse strains,
is also associated with active chronic hepatitis and development of
hepatocellular carcinoma in both inbred and knockout strains of
mice [42,43,44]. H. hepaticus is now widely used to examine the
role of intestinal microbiota on host inflammatory responses.
Consistent with our findings, these examples collectively demon-
strate a balance within the gut-liver axis appears critical in
mediating host-pathogen equilibrium, a failure of which can result
in detrimental consequences in both intestinal, liver, and systemic
health [38,45]. The source or stimuli for local and systemic
changes in cytokines and chemokines remains uncertain. Systemic
cytokine levels correlate with observed pathologies determined by
PLS-based modeling in a complex data and also predictive for
known biomarkers of injury such as serum ALT for liver necrosis.
While it is outside the scope of this study to definitively
characterize the source (colon or liver) and cell type responsible
for circulating cytokines and chemokines observed at 3 and 7 DPI,
this is an active area of research and future studies will hopefully
clarify our understanding of the pathogenesis of hepatocellular
necrosis in this model.
Additional studies in our laboratory examining liver injury at
early stages of C. rodentium pathogenesis have confirmed that acute
hepatic injury in this model is reproducible (unpublished results).
Specifically, the incidence of liver necrosis at 3 DPI was increased
to 5/6 animals following an overnight fast prior to necropsy,
with an increased hepatitis index noted in the absence of
hepatocellular necrotic lesions by 7 DPI. Timepoint controls
demonstrated no observable liver necrosis or appreciable eleva-
Figure 8. Liver-specific PLS-DA analysis of C. rodentium infected C57BL/6 mice at 3 DPI. (A) Partial least squares discriminate analysis (PLS-
DA) showing separation of mice with and without necrosis using the first two principal components. (B) Cytokine covariation based on class
discrimination using cytokine targets as independent variables (X, black triangles) and pathological states (presence or absence of necrotic lesions)
as the dependent dummy variables (Y, red squares). (C) Variables in projection (VIPs) for the principal components 1 and 2, where values .1 have
positive influence in discriminating between classes. Table represents the liver-specific VIPs and their respective scores that best discriminate necrotic
from non-necrotic mice at 3 DPI.
doi:10.1371/journal.pone.0033099.g008
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and not a result of animal handling or stress. To better understand
the temporal kinetics of injury, collecting serial bleeds from
animals preceding, during, and under conditions of resolving liver
injury could be insightful towards understanding the kinetics of
cytokine production and whether these biomarkers of inflamma-
tion are precursors to injury or simply a consequence. Further-
more, use of specific neutralizing antibodies or conditional
knockout studies may help to further elucidate the importance of
these markers in the predisposition and severity of liver injury and
homeostasis.
In conclusion, we show for the first time distinct liver pathology
associated with enteric infection with C. rodentium in C57BL/6
mice, characterized by increased inflammation and hepatitis
index scores as well as prominent periportal hepatocellular
coagulative necrosis indicative of thrombotic ischemic injury
during the early course of C. rodentium pathogenesis. Histologic
changes in the liver correlate with serum elevation of liver
transaminases, systemic and hepatic cytokine and chemokine
changes, as well as signal transduction changes prior to peak
bacterial colonization and colonic disease. C. rodentium infection in
C57BL/6 mice appears to be a useful new model to study acute
liver injury and inflammatory stress under conditions of gastro-
intestinal infection analogous to enteropathogenic E. coli infection
in humans.
Materials and Methods
Ethics Statement
The Institutional Animal Care and Use Committee (IACUC) at
the Massachusetts Institute of Technology (MIT) (0207-020-10)
approved all animal experiments described.
Mouse Infections
24 female 8–10 week old (,20 gram) C57BL/6J (The Jackson
Laboratory, Bar Harbor, ME) mice were housed six per
microisolator cage in a specific pathogen-free facility approved
by the Association for Assessment and Accreditation of Laboratory
Animal Care. Animals were maintained on pelleted rodent chow
(LabDiet, Purina Mills, Inc., Richmond, IN), water ad libitum and
allowed to acclimate one week prior to experimentation. Infectious
colitis was induced by intragastric inoculation with ,1610
9 CFU
of C. rodentium (DBS120) in 3% sodium bicarbonate (w/v in 16
phosphate buffered saline (PBS), pH 7.4), 100 mL volume as
described previously [46], while the uninoculated control groups
received 100 mL of 3% sodium bicarbonate vehicle. Control
animals (0 DPI) were euthanized within 1 hr of inoculation and
infection kinetics (3, 7, 14 DPI animals) was monitored by fecal
shedding (3, 7, 10, 14 DPI) determined by plating serial 10
dilutions of fecal slurries (10% [w/v] in 16PBS, pH 7.4) on LB
agar with selection for kanamycin. At their respective timepoints,
Figure 9. Liver-specific OPLS analysis of C. rodentium infected animals at 3 DPI. OPLS analysis of C. rodentium infected animals at 3 DPI
using serum cytokines and chemistries (X) for prediction of ALT levels (Y). (A) Mice segregated well in the predictive component (principal
component 1) with an R
2X (1)=0.35, indicating this component captured ,35% of the variance present in the X variables. (B) The predictive weight
and covariation of serum targets (X variables, black triangles) in relation to serum ALT (Y, red square). (C) Observed vs predicted plot for ALT
resulted in a R
2=0.9892 indicating a highly predictive model based on hepatic cytokines. (D) Table representing the VIPs .1 for the predictive
component for serum ALT.
doi:10.1371/journal.pone.0033099.g009
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terminal cardiac puncture for serum chemistries and cytokines
analysis (stored at 280uC until processing), and animals
necropsied for tissue collection (flash frozen in liquid nitrogen,
and stored at 280uC until processing).
Histopathology
Colons and livers were formalin-fixed (10%), paraffin-embed-
ded, and 5 m sections stained by H&E for histological assessment
by a board certified veterinary pathologist blinded to study
treatment groups. Disease severity of colonic sections was based on
an existent method assessing inflammation, edema, epithelial
defects, crypt atrophy, hyperplasia, and dysplasia and graded on a
scale from 0 to 4. Livers were assessed for both inflammatory and
necrotic parameters. Degree of hepatic inflammation was graded
on a scale from 0 to 4 based on region (lobular, portal, and
interface), and the number of lobes with $5 inflammatory foci was
noted. The summation of these categorical inflammatory scores
resulted in a hepatitis index; mice with a score $4 were defined as
having hepatitis.
Figure 10. Most influential variables in serum and liver obtained from PLS-DA and OPLS models. Combined models for PLS-DA (necrosis
state) and OPLS (Y=ALT) were generated using data collected on 3 DPI. Targets in bold are those that were found influential in both serum and liver.
doi:10.1371/journal.pone.0033099.g010
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degree, and pattern of liver necrosis. The overall degree or grade
of necrosis was scored from 0 to 4 on the basis of the severity and
distribution of the necrotic lesions and the number of lobes
affected as follows: 0 – None, 1 – Minimal to Mild, 2 – Moderate,
3 – Marked, 4 – Severe to Diffuse. To aid the overall grading the
distribution of necrosis was evaluated as follows: 0 – None, 1 –
Focal, 2 – Multifocal, 3 – Translobular, 4 – Submassive to
Massive, involving multiple lobules or the entire lobe or multiple
lobes. The histological pattern of liver injury was evaluated as
centrilobular, midzonal, or periportal in nature (0=none,
1#=low, 2 ##=medium, 3 ###=high).
Immunohistochemistry
Formalin-fixed paraffin-embedded livers and intestinal sections
were stained to assess the degree of proliferation (Ki-67) and
apoptosis (activated caspase 3). Anti-activated caspase 3 (Cell
Signaling Technologies, Inc., Beverly, MA) and anti-Ki-67
antibodies were used as specified by the manufacturer. Antibodies
were detected with biotinylated goat anti-rabbit IgG (Sigma-
Aldrich, St. Louis, MO) and sections visualized with diaminoben-
zidine and hematoxylin counterstained. For quantification of Ki-
67 labeling index, the average number of KI-67
+ cells/mm
2 liver
determined in 15 fields (magnification, 4006, 3 fields/lobe) per
mouse (n=3 for 0, 7, and 14 DPI; n=2 for 3 DPI (necrosis
bearing); n=1 for 3 DPI (no necrosis)). Data was represented as
box-whisker plots, where boxes represent the first to third quartile
and a horizontal line indicates the median. Bars represent ranges.
Groups were compared by one-way ANOVA with Tukey’s
multiple comparison test.
Clinical Chemistries
Serum samples were thawed on ice and diluted 1:4 in sterile
ddH20 and processed on an Olympus AU 400e serum chemistry
analyzer (Beckman Coulter, Inc., Brea, CA) for 18 serum
chemistry targets. All samples were run against internal standards
and machine calibrated prior to use as specified by the
manufacturer.
Multiplex Detection of Serum Cytokines and Chemokines
Mouse serum collected at necropsy was processed using mouse
23-plex cytokine panels (Bio-Rad, Hercules, CA) as specified by
the manufacturer. Briefly, serum was diluted in species-specific
sample diluent (1:4) and 50 mL of sample or premixed standards
were incubated with pre-washed target capture antibody-conju-
gated microspheres provided and incubated for 30 minutes with
orbital shaking (300 rpm) in a 96-well plate. Upon washing, beads
were incubated with detection antibody (30 min), washed, and
subsequently incubated with streptavidin-PE (10 min). Beads were
washed and resuspended with 125 mL assay buffer and read on the
Luminex 200 suspension array system using the low RP1 target
setting (High PMT) for maximum sensitivity. Data analysis was
carried out with the Bio-Plex Manager
TM 5.0 software and
cytokine or chemokine concentrations calculated against an 8
point standard curve generated by either 4PL or 5PL curve fitting.
Multiplex Detection of Liver Cytokines, Chemokines, and
Phospho-Signaling
Colon and livers were thawed on ice and ,30–50 mg of liver
was briefly washed with 500 mL ice-cold cell wash buffer (Bio-Rad,
Hercules, CA). Livers were then transferred to a clean pre-weighed
Table 1. PLS-DA and OPLS component contributions for discrimination (R
2 Y) and variance (Q
2) of necrosis at 3 DPI.
Serum Model
Component R
2YR
2Y (cumulative) Q
2 Q
2 (cumulative) Model Type
1 0.789 0.789 0.441 0.441
2 0.168 0.957 20.336 0.385
3 0.030 0.987 0.343 0.596 PLS-DA: 3DPI
1 (P) 0.842 0.842 0.547 0.547
2 (O) 0.081 0.923 0.137 0.684
3 (O) 0.056 0.980 0.198 0.882 OPLS: 3DPI (ALT)
Liver Model
Component R
2YR
2Y (cumulative) Q
2 Q
2 (cumulative) Model Type
1 0.735 0.735 0.492 0.492
2 0.248 0.984 0.656 0.825
3 0.015 0.999 0.860 0.976 PLS-DA: 3DPI
1 (P) 0.783 0.783 0.522 0.522
2 (O) 0.208 0.991 0.234 0.756
3 (O) 0.006 0.997 0.132 0.888 OPLS: 3DPI (ALT)
Combined Model
Component R
2YR
2Y (cumulative) Q
2 Q
2 (cumulative) Model Type
1+2 (27 targets) 0.983 0.983 0.987 0.987 PLS-DA: 3DPI
1+2 (13 targets) 0.994 0.994 0.976 0.976 PLS-DA: 3DPI
P+O (26 targets) 0.996 0.996 0.960 0.960 OPLS: 3DPI (ALT)
Model results are indicated based on using serum or tissue targets alone as well as combined models using the top variables from each independent model.
doi:10.1371/journal.pone.0033099.t001
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lysis buffer (Bio-Rad, Hercules, CA). Tissues were homogenized
on ice for 1 minute with a Tissue Tearor
TM and subsequently
frozen to 280uC overnight. Tissues were then thawed on ice and
sonicated on level 5 with 5 short (,3 sec) bursts. Upon sonication,
lysates were centrifuged for 10 minutes (5,000 rpm, 4uC).
Resultant supernatant was carefully removed, protein quantified
by BCA protein assay (Thermo Scientific, Rockford, IL), and
adjusted to 1 mg/mL with 16 PBS + 0.5% BSA (w/v). 50 mLo f
adjusted lysate was subsequently loaded on to a Mouse Group I:
23-Plex panel (Bio-Rad, Hercules, CA) and standards resuspended
in the appropriate matrix. Samples were subsequently processed as
specified above for serum cytokines and chemokines analysis using
the Bio-Plex array system and software manager.
Immunoblot of Phospho-proteins
Tissues were thawed on ice, suspended in Bio-Rad cell lysis
buffer with provided phosphatase and protease inhibitors, and
homogenized with a Tissue Tearor
TM for 1 minute. Upon freeze
thawing (280uC), samples were sonicated on level 5 for three
10 second bursts, incubated on ice for 20 minutes, and centrifuged
at 4uC at 5000 rpm for 15 minutes to precipitate insolubles.
Supernatants were protein quantified by BCA (Thermo Scientific,
Rockford, IL) and adjusted to 2 mg/mL with Bio-Rad lysis buffer.
Equal volumes of 26 SDS loading buffer was added and 20 mL
loaded (20 mg/well) onto 10% SDS Tris-glycine gels (Invitrogen,
Carlsbad, CA). Upon transfer to immobolin
PQ PVDF membranes,
blots were incubated with antibodies (1:2000 P-STAT-3, 1:2000
anti-rabbit monoclonal (Cell Signaling Technologies, Danvers,
MA) in TBST-5%BSA, incubated with Santa Cruz luminal
reagent, exposed by Kodak MR film, and quantified by NIH
imageJ.
PLS-DA and OPLS Analysis
The data was mean centered, variance scaled, log10 trans-
formed, and analyzed by multivariate analysis using SIMCA-P
11.5 software (Umetrics Inc., Kinnelon, NJ). PCA analysis was
used to reduce the dimensionality of the data set and to assess the
covariation of variance across measured targets. PLS-DA analysis
was used to determine the features that best differentiated between
selected groups of animals designated as classes (i.e., mice with or
without hepatocellular necrosis). OPLS analysis was used to
determine the features that best correlated with a desired Y
variable, such as ALT levels or degree of necrosis/hepatitis,
resulting in variable importance in the projection (VIP). VIPs
greater $1 were considered significant in their contribution to the
model predicting the dependent variable (Y) of interest. Model
quality was assessed and reported using the following parameters:
R
2 Y, the fraction of the sum of squares of all Y variables
explained by the component of the model, and R
2 Y cumulative,
the cumulative sum of squares of all Y variables explained by all
components of the model. Q
2 is the fraction of the total variation
in Y variables that can be predicted by the component, and Q
2
cumulative is the cumulative Q
2 of the Y variables for all
components in the model. An R
2 cumulative and Q
2 cumulative of
1 indicate a perfect fit, with 100% of the relationship between X
variables and Y variables explained.
Statistical Analysis
Statistical significance in body weight change, bacterial load,
disease indices, cytokine changes, clinical chemistries, and
phosphorylation levels was determined by comparing control or
experimental groups by either student’s T-test or by two-way
analysis of variance (ANOVA) followed by Tukey’s post tests. Data
demonstrating non-normal distributions or categorical in nature
(i.e., pathology scores) were assessed by Kruskal-Wallis non-
parametric test with Dunn’s multiple comparison test against
controls unless otherwise indicated. If only two groups were
analyzed, Mann Whitney was utilized. All analyses were done
using GraphPad Prism software version 4.0 (La Jolla, CA), and P
values of ,0.05 were considered significant.
Supporting Information
Figure S1 Infection kinetics and body weight changes in
C57BL/6 mice infected with C. rodentium. C. rodentium
bacterial burden (A) was detectable by 3DPI and maximal around
7 DPI with clearance beginning by 10 DPI. Monitoring of body
weights (B) demonstrated no statistically significant weight loss
over the course of infection.
(TIF)
Figure S2 Serum chemistry changes in C57BL/6 mice
inoculated with C. rodentium. Systemic parameters assessing
liver function (ALT, AST, ALP, total bilirubin), kidney function
(creatinine, BUN, CPK) and electrolytes (Ca
2+,C l
2,N a
+,K
+)
were measured at 0, 3, 7, and 14 DPI. (One-way ANOVA with
Tukey’s multiple comparison test: * P,0.05, ** P,0.01, ***
P,0.001). Lines indicate group means.
(TIF)
Figure S3 Systemic cytokine and chemokine changes
induced by C. rodentium infection in C57BL/6 mice.
Serum cytokines and chemokines were measured by quantitative
multiplex analysis using Luminex technology. (One-way ANOVA
with Tukey’s multiple comparison test: * P,0.05, ** P,0.01, ***
P,0.001). Lines indicate group means (n=5 to 6 animals per
timepoint).
(TIF)
Figure S4 Liver cytokine and chemokine changes in-
duced by C. rodentium infection in C57BL/6 mice. Liver
cytokines and chemokines were measured by quantitative
multiplex analysis using Luminex technology. Statistically signif-
icant changes as a group were only found for IL-1b (L), MCP-1
(L), MIP-1a (L), and RANTES (L) (One-way ANOVA with
Dunnett’s multiple comparison test comparing all columns to
controls: * P,0.05, ** P,0.01, *** P,0.001). Lines indicate
group means (n=6 livers per timepoint).
(TIF)
Figure S5 PLS-DA analysis of 3 and 7 DPI animals.
Animals were assigned one of three classes; 3DPI (no necrosis), 3
DPI (necrosis), and 7 DPI. (A) Animal separation based on the first
two principal components. (B) Target covariation using all serum
target, liver targets, and histological scores.
(TIF)
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